Journal of Health Services Research & Policy > Volume 13, Number 4 > Pp. 215-221

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Cooper, R. Articles by Ward, P. Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

Original research

Stakeholders' views of UK nurse and pharmacist supplementary prescribing

Richard Cooper , Claire Anderson, Tony Avery ¹, Paul Bissell ², Louise Guillaume ², Allen Hutchinson ², Joanne Lymn ³, Elizabeth Murphy ⁴, Julie Ratcliffe ⁵, Paul Ward ⁶

Centre for Pharmacy, Health and Society, University of Nottingham, Nottingham, UK; ¹ Community Health Sciences, University of Nottingham, Nottingham, UK; ² Section of Public Health, ScHARR, University of Sheffield, Sheffield, UK; ³ School of Nursing, University of Nottingham, Nottingham, UK; ⁴ School of Sociology & Social Policy, University of Nottingham, Nottingham, UK; ⁵ School of Nursing and Midwifery, University of South Australia, Adelaide, Australia; ⁶ School of Medicine, Flinders University, Bedford Park, Australia

Correspondence to: Richard.cooper{at}nottingham.ac.uk

Objectives: Supplementary prescribing (SP) by pharmacists and nurses in the UK represents a unique approach to improving patients' access to medicines and better utilizing health care professionals' skills. Study aims were to explore the views of stakeholders involved in SP policy, training and practice, focusing upon issues such as SP benefits, facilitators, challenges, safety and costs, thereby informing future practice and policy.

Method: Qualitative, semi-structured interviews were conducted with 43 purposively sampled UK stakeholders, including pharmacist and nurse supplementary prescribers, doctors, patient groups representatives, academics and policy developers. Analysis of transcribed interviews was undertaken using a process of constant comparison and framework analysis, with coding of emergent themes.

Results: Stakeholders generally viewed SP positively and perceived benefits in terms of improved access to medicines and fewer delays, along with a range of facilitators and barriers to the implementation of this form of non-medical prescribing. Stakeholders' views on the economic impact of SP varied, but safety concerns were not considered significant. Future challenges and implications for policy included SP being potentially superseded by independent nurse and pharmacist prescribing, and the need to improve awareness of SP. Several potential tensions emerged including nurses' versus pharmacists' existing skills and training needs, supplementary versus independent prescribing, SP theory versus practice and prescribers versus non-prescribing peers.

Conclusion: SP appeared to be broadly welcomed by stakeholders and was perceived to offer patient benefits. Several years after its introduction in the UK, stakeholders still perceived several implementation barriers and challenges and these, together with various tensions identified, might affect the success of supplementary and other forms of non-medical prescribing.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. O. Baerlocher and A. S. Detsky Professional Monopolies in Medicine JAMA, February 25, 2009; 301(8): 858 - 860. [Full Text] [PDF]